Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX15 | P16050 | 1/20 | 0.43 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.43 |
| ▸ | GAA | P10253 | 3/20 | 0.39 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.39 |
| ▸ | MEN1 | O00255 | 3/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.34 |
| ▸ | NPC1 | O15118 | 2/20 | 0.34 |
| ▸ | MAPT | P10636 | 2/20 | 0.34 |
| ▸ | AHR | P35869 | 1/20 | 0.34 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.34 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.34 |
| ▸ | THRB | P10828 | 1/20 | 0.34 |
| ▸ | HK1 | P19367 | 1/20 | 0.34 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.34 |
| ▸ | RECQL | P46063 | 1/20 | 0.34 |
| ▸ | RAB9A | P51151 | 1/20 | 0.34 |
| ▸ | GALK1 | P51570 | 1/20 | 0.34 |
| ▸ | BLM | P54132 | 1/20 | 0.34 |
| ▸ | HKDC1 | Q2TB90 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4502710 | 0.78 | ALOX15 (0.41) | ALOX15HSD17B10GAANPSR1MEN1 | |
| SCHEMBL3003659 | 0.78 | ALOX15 (0.41) | ALOX15HSD17B10GAANPSR1MEN1 | |
| SCHEMBL24953238 | 0.78 | GAA (0.38) | ALOX15HSD17B10GAANPSR1MEN1 | |
| SCHEMBL11442903 | 0.75 | ALOX15 (0.42) | ALOX15HSD17B10GAANPSR1MEN1 | |
| SCHEMBL15360012 | 0.72 | CHRNB2 (0.38) | GAAMAPT | |
| SCHEMBL29412510 | 0.71 | CA12 (0.57) | NPSR1MAPTRAB9AALDH1A1MAOA | |
| SCHEMBL30345255 | 0.71 | HTR5A (0.38) | HSD17B10GAANPC1MAPTKDM4E | |
| SCHEMBL26168163 | 0.71 | CA12 (0.57) | NPSR1MAPTRAB9AALDH1A1MAOA | |
| SCHEMBL23571603 | 0.71 | ALDH1A1 (0.41) | HSD17B10GAAMAPTKDM4EHTR5A | |
| SCHEMBL17430748 | 0.71 | HTR5A (0.38) | HSD17B10GAANPC1MAPTKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 223 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4611899-A1 | ALLOSTERIC CHROMENONE INHIBITORS OF PHOSPHOINOSITIDE 3-KINASE (PI3K) FOR THE TREATMENT OF DISEASE | Petra Pharma Corporation (US) | 2025-09-10 | — | — | EP | claimed |
| US-20240182460-A1 | ALLOSTERIC CHROMENONE INHIBITORS OF PHOSPHOINOSITIDE 3-KINASE (PI3K) FOR THE TREATMENT OF DISEASE | PETRA PHARMA CORPORATION | 2024-06-06 | — | — | US | claimed |
| CN-115850200-B | Polymerizable 3, 1-benzoxazine substituted phenol monomer, preparation method, cured product and application | 西安交通大学 | 2024-05-14 | — | — | CN | claimed |
| WO-2024097172-A1 | ALLOSTERIC CHROMENONE INHIBITORS OF PHOSPHOINOSITIDE 3-KINASE (PI3K) FOR THE TREATMENT OF DISEASE | PETRA PHARMA CORPORATION (US) | 2024-05-10 | — | — | WO | claimed |
| CN-115850200-A | Polymerizable 3, 1-benzoxazine substituted phenol monomer, preparation method, cured product and application | 西安交通大学 | 2023-03-28 | — | — | CN | claimed |
| CN-110204506-B | CO 2 Synthesis of 1,4-dihydro-2H-3,1-benzoxazine-2-one derivative as C1 source | 常州大学 | 2022-10-28 | — | — | CN | claimed |
| EP-2928888-A1 | SUBSTITUTED PYRIDOPYRAZINES AS SYK INHIBITORS | Hutchison Medipharma Limited (CN) | 2015-10-14 | — | — | EP | claimed |
| WO-2014086316-A1 | SUBSTITUTED PYRIDOPYRAZINES AS SYK INHIBITORS | HUTCHISON MEDIPHARMA LIMITED (CN) | 2014-06-12 | — | — | WO | claimed |
| EP-2570418-A2 | 2,3-dihydro-6-nitroimidazo[2,1-b]oxazoles compound | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2013-03-20 | — | — | EP | claimed |
| US-7674502-B2 | bright gold, fluxing agents such as organometallics | FERRO GMBH (DE) | 2010-03-09 | — | — | US | claimed |
| US-20070243336-A1 | Uv-Radiation-Curable Precious-Metal Preparation, Transfer Pictures Containing Said Preparation, and Process for Decoration | Heraeus Deutschland GmbH & Co. KG (DE) | 2007-10-18 | — | — | US | claimed |
| US-7262212-B2 | 2,3-dihydro-6-nitroimidazo[2,1-b]oxazoles | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2007-08-28 | — | — | US | claimed |
| US-20060134554-A1 | Radiationhardenable printing media, transfer pictures produced therewith, and method for producing ceramic decorations | FERRO GMBH (DE) | 2006-06-22 | — | — | US | claimed |
| US-20060094767-A1 | 2,3-Dihydro-6-nitroimidazo[2,1-b]oxazoles | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2006-05-04 | — | — | US | claimed |
| CN-1753957-A | Radiation-curable printing medium, transfer article made therefrom and method for making ceramic decorations | FERRO GMBH (DE) | 2006-03-29 | — | — | CN | claimed |
| EP-1597326-A1 | RADIOHARDENABLE PRINTING MEDIA, TRANSFER PICTURES PRODUCED THEREWITH, AND METHOD FOR PRODUCING CERAMIC DECORATIONS | Ferro GmbH (DE) | 2005-11-23 | — | — | EP | claimed |
| EP-1555267-A1 | 2,3-DIHYDRO-6-NITROIMIDAZO 2,1-b OXAZOLES | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2005-07-20 | — | — | EP | claimed |
| WO-2004076569-A1 | RADIOHARDENABLE PRINTING MEDIA, TRANSFER PICTURES PRODUCED THEREWITH, AND METHOD FOR PRODUCING CERAMIC DECORATIONS | FERRO GMBH (DE) | 2004-09-10 | — | — | WO | claimed |
| US-5300497-A | Broad spectrum antibiotics and bactericides; stable to beta-lactamase; effective against antibiotic-resistant bacteria | TOYAMA CHEMICAL CO., LTD. (JP) | 1994-04-05 | — | — | US | claimed |
| US-5185330-A | Penicillins/ad/ | TOYAMA CHEMICAL CO., LTD. (JP) | 1993-02-09 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060094767-A1 | 2,3-Dihydro-6-nitroimidazo[2,1-b]oxazoles | NR2C2, NR4A3, NR4A2 | ALOX15 2847/4885HSD17B10 467/4885GAA 4165/4885 |
| US-20240182460-A1 | ALLOSTERIC CHROMENONE INHIBITORS OF PHOSPHOINOSITIDE 3-KINASE (PI3K) FOR THE TREATMENT OF DISEASE | PIK3CA, PIK3R4, PIK3R5 | ALOX15 2996/4885HSD17B10 466/4885GAA 1820/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.